PMID: 6988774Mar 1, 1980Paper

Lipoprotein lipase. Interest in clinical biochemistry (author's transl)

J Etienne, J Debray


Lipoprotein lipase (LPL) is an enzyme which hydrolyses triglycerides especially VLDL and chylomicrons triglycerides. The measurement of LPL can be of interest in clinical biochemistry. There is no LPL in blood circulation, but it is possible to release it by heparin intravenous injection. However, heparin releases also other enzymes, particularly hepatic triglyceride lipase (HTGL). It is then post-heparin lipolytic activity (PHLA) which is determined. It is possible to measure separately LPL and HTGL, by using antibodies or inhibitors so chosen to be specific to one or the other enzyme. The main variations of LPL and HTGL in various diseases or treatments at present known are reported. LPL has also been recently involved in atherosclerosis pathogeny.

Related Concepts

Fat Pad
Lipoprotein LIPASE
Lipoproteins, VLDL1

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.